Quantinno Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Quantinno Capital Management's AMRX Position: Q3 2026 in Review
Quantinno Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 3.6% in Q3 2026, selling an estimated $135K and leaving 201,561 shares worth $4.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1608.
Quantinno Capital Management first reported a position in AMRX in Q2 2025 and has held it in 6 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Quantinno Capital Management held 201,561 shares of Amneal Pharmaceuticals worth $4.06M as of Q3 2026.
- Quantinno Capital Management sold 7,469 Amneal Pharmaceuticals shares in Q3 2026, an estimated $135K.
- Amneal Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1608 holding.
- Quantinno Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.